Novel Drugs Targeting the Epidermal Growth Factor Receptor and Its Downstream Pathways in the Treatment of Colorectal Cancer: A Systematic Review

Colorectal cancer is the second most common malignancy among men and women in the United States, and the 5-year survival rate remains poor despite recent advances in chemotherapy and targeted agents. The mainstay of therapy for advanced disease remains the cytotoxic chemotherapy including 5-FU, irin...

Descripción completa

Detalles Bibliográficos
Autores principales: Merla, Amartej, Goel, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477664/
https://www.ncbi.nlm.nih.gov/pubmed/23097702
http://dx.doi.org/10.1155/2012/387172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477664/
https://www.ncbi.nlm.nih.gov/pubmed/23097702
http://dx.doi.org/10.1155/2012/387172

Ejemplares similares